Assessing suicidal risk with antiepileptic drugs

Marco Mula2, Gail S Bell1, Josemir W Sander1,31Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, London, United Kingdom; 2Department of Clinical and Experimental Medicine, Division o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marco Mula, Gail S Bell, Josemir W Sander
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/98914a0b680d4ade83e1ffc2b73a0848
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:98914a0b680d4ade83e1ffc2b73a0848
record_format	dspace
spelling	oai:doaj.org-article:98914a0b680d4ade83e1ffc2b73a08482021-12-02T05:15:24ZAssessing suicidal risk with antiepileptic drugs1176-63281178-2021https://doaj.org/article/98914a0b680d4ade83e1ffc2b73a08482010-09-01T00:00:00Zhttp://www.dovepress.com/assessing-suicidal-risk-with-antiepileptic-drugs-a5270https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Marco Mula2, Gail S Bell1, Josemir W Sander1,31Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, London, United Kingdom; 2Department of Clinical and Experimental Medicine, Division of Neurology, Amedeo Avogadro University, University Hospital Maggiore della Carit&agrave;, Novara, Italy; 3SEIN &ndash; Epilepsy Institute in the Netherlands Foundation, Heemstede, The NetherlandsAbstract: Recently, the US Food and Drug Administration issued an alert about an increased risk for suicidality during treatment with antiepileptic drugs (AEDs) for different indications, including epilepsy. We discuss the issue of suicide in epilepsy with special attention to AEDs and the assessment of suicide in people with epilepsy. It has been suggested that early medical treatment with AEDs might potentially reduce suicide risk of people with epilepsy, but it is of great importance that the choice of drug is tailored to the mental state of the patient. The issue of suicidality in epilepsy is likely to represent an example of how the underdiagnosis of psychiatric symptoms, the lack of input from professionals (eg, psychologists, social workers, and psychiatrists), and the delay in an optimized AED therapy may worsen the prognosis of the condition with the occurrence of severe complications such as suicide.Keywords: epilepsy, suicide, adverse effect, depression Marco MulaGail S BellJosemir W SanderDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 613-618 (2010)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Marco Mula Gail S Bell Josemir W Sander Assessing suicidal risk with antiepileptic drugs
description	Marco Mula2, Gail S Bell1, Josemir W Sander1,31Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, London, United Kingdom; 2Department of Clinical and Experimental Medicine, Division of Neurology, Amedeo Avogadro University, University Hospital Maggiore della Carit&agrave;, Novara, Italy; 3SEIN &ndash; Epilepsy Institute in the Netherlands Foundation, Heemstede, The NetherlandsAbstract: Recently, the US Food and Drug Administration issued an alert about an increased risk for suicidality during treatment with antiepileptic drugs (AEDs) for different indications, including epilepsy. We discuss the issue of suicide in epilepsy with special attention to AEDs and the assessment of suicide in people with epilepsy. It has been suggested that early medical treatment with AEDs might potentially reduce suicide risk of people with epilepsy, but it is of great importance that the choice of drug is tailored to the mental state of the patient. The issue of suicidality in epilepsy is likely to represent an example of how the underdiagnosis of psychiatric symptoms, the lack of input from professionals (eg, psychologists, social workers, and psychiatrists), and the delay in an optimized AED therapy may worsen the prognosis of the condition with the occurrence of severe complications such as suicide.Keywords: epilepsy, suicide, adverse effect, depression
format	article
author	Marco Mula Gail S Bell Josemir W Sander
author_facet	Marco Mula Gail S Bell Josemir W Sander
author_sort	Marco Mula
title	Assessing suicidal risk with antiepileptic drugs
title_short	Assessing suicidal risk with antiepileptic drugs
title_full	Assessing suicidal risk with antiepileptic drugs
title_fullStr	Assessing suicidal risk with antiepileptic drugs
title_full_unstemmed	Assessing suicidal risk with antiepileptic drugs
title_sort	assessing suicidal risk with antiepileptic drugs
publisher	Dove Medical Press
publishDate	2010
url	https://doaj.org/article/98914a0b680d4ade83e1ffc2b73a0848
work_keys_str_mv	AT marcomula assessingsuicidalriskwithantiepilepticdrugs AT gailsbell assessingsuicidalriskwithantiepilepticdrugs AT josemirwsander assessingsuicidalriskwithantiepilepticdrugs
_version_	1718400485816270848

Assessing suicidal risk with antiepileptic drugs

Ejemplares similares